Quarterly report pursuant to Section 13 or 15(d)

Warrants (Details)

v3.24.1.1.u2
Warrants (Details)
3 Months Ended
Mar. 31, 2024
USD ($)
$ / shares
shares
Number of shares, Beginning balance | shares 17,037,500
Number of shares, Ending balance | shares 18,018,750
Warrant [Member]  
Number of shares, Beginning balance | shares 2,550,000
Number of Shares, Grants $ 0
Number of Shares, Expirations | shares 0
Number of Shares, Exercised $ 0
Number of shares, Ending balance | shares 2,550,000
Number of Shares, Exercisable | shares 2,550,000
Weighted Average Exercise Price, Beginning balance $ 0.70
Weighted Average Exercise Price, Grants 0
Weighted Average Exercise Price, Expirations 0
Weighted Average Exercise Price, Exercised 0
Weighted Average Exercise Price, Ending balance 0.70
Weighted Average Exercise Price, Exercisable $ 0.70
Weighted Average Remaining Contractual Life years, Beginning Balance 7 months 6 days
Weighted Average Remaining Contractual Life years, Ending Balance 4 months 6 days
Weighted Average Remaining Contractual Life years, Exercisable 4 months 6 days
Aggregate Intrinsic Value, Beginning balance | $ $ 0
Aggregate Intrinsic Value, Grants | $ 0
Aggregate Intrinsic Value, Expirations | $ 0
Aggregate Intrinsic Value, Exercised | $ 0
Aggregate Intrinsic Value, Exercisable | $ 0
Aggregate Intrinsic Value, Ending balance | $ $ 0